Down-regulated MAC30 expression inhibits proliferation and mobility of human gastric cancer cells

Cellular Physiology and Biochemistry

Volumn 33, Issue 5, 2014, Pages 1359-1368

  Xu, Xiao Yan ^a   Zhang, Li Juan ^a   Yu, Yan Qiu ^a   Zhang, Xiao Tong ^b   Huang, Wan Jing ^b   Nie, Xiao Cui ^c   Song, Guo Qing ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b China Medical University Clinical Medicine Seven year   (China)

^c Maternity and Infant Hospital of Shenyang   (China)

Author keywords

Gastric carcinoma; Invasion; Lampodia; MAC3

Indexed keywords

F ACTIN; MAC30 PROTEIN; PROTEIN; PROTEIN KINASE B; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; MEMBRANE PROTEIN; MESSENGER RNA; TMEM97 PROTEIN, HUMAN; GELATINASE A;

APOPTOSIS; ARTICLE; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; GASTRIC CANCER CELL LINE; GENE SILENCING; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; STOMACH CANCER; TUMOR LOCALIZATION; UPREGULATION; CELL CYCLE; CELL MOTION; DEFICIENCY; GENETICS; METABOLISM; PATHOLOGY; STOMACH TUMOR; TUMOR CELL CULTURE; APOPTOSIS ASSAY; CANCER CELL; CARCINOMA CELL LINE; CELL CYCLE ASSAY; CELL CYCLE PROGRESSION; CELL INVASION ASSAY; CELL MIGRATION ASSAY; CELL MOTILITY; CELL PROLIFERATION ASSAY; GENETIC TRANSFECTION; PHENOTYPE; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; STOMACH CARCINOMA; WESTERN BLOTTING;

CELL CYCLE; CELL MOVEMENT; CELL PROLIFERATION; DOWN-REGULATION; HUMANS; MEMBRANE PROTEINS; RNA, MESSENGER; STOMACH NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 84900901737     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000358703     Document Type: Article

References (25)

1. Kelley JR, Duggan JM: Gastric cancer epidemiology and risk factors. J Clin Epidemiol 2003;56:1-9. (Pubitemid 36183309)
2. Murphy M, Pykett MJ, Harnish P, Zang KD, George DL: Identification and characterization of genes differentially expressed in meningiomas. Cell Growth Differ 1993;4:715-722.
3. Kayed H, Kle eff J, Ding J, Hammer J, Giese T, Zentgraf H, Buchler MW, Friess H: Expression analysis of MAC30 in human pancreatic cancer and tumors of the gastrointestinal tract. Histol Histopathol 2004;19:1021-1031. (Pubitemid 39386761)
4. Bartz F, Kern L, Erz D, Zhu M, Gilbert D, Meinhof T, Wirkner U, Erfle H, Muckenthaler M, Pepperkok R, Runz H: Identification of cholesterol-regulating genes by targeted RNAi screening. Cell Me tab 2009;10:63-75.
5. Wilcox CB, Feddes GO, Willett-Brozick JE, Hsu LC, DeLoia JA, Baysal BE: Coordinate up-regulation of TMEM97 and cholesterol biosynthesis genes in normal ovarian surface epithelial c ells treated with progesterone: Implications for pathogenesis of ovarian cancer. BMC Cancer 2007;7:223.
6. Malhotra K, Luehrsen KR, Costello LL, Raich TJ, Sim K, Foltz L, Davidson S, Xu H, C hen A, Yamanishi DT, Lindemann GW, Cain CA, Madlansacay MR, Hashima SM, Pham TL, Mahoney W, Schueler PA: Identification of differentially expressed mRNAs in human fetal liver across gestation. Nucleic Acids Res 1999;27:839-847. (Pubitemid 29209373)
7. Zhang ZY, Zhao ZR, Adell G, Jarlsfelt I, Cui YX, Kayed H, Kleeff J, Wang MW, Sun XF: Expression of MAC30 in rectal cancers with or without preoperative radiotherapy. On cology 2006;71:259-265.
8. Moparthi SB, Arbman G, Wallin A, Kayed H, Kleeff J, Zentgraf H, Sun XF: Expression of MAC30 protein is related to survival and biological variables in primary and metastat ic colorectal cancers. Int J Oncol 2007;30:91-95.
9. Yang S, Li H, Liu Y, Ning X, Meng F, Xiao M, Wang D, Lou G, Zhang Y: Elevated expression of MAC30 predicts lymph node metastasis and unfavorable prognosis in patients with epithelial ovarian cancer. Med Oncol 2013;30:324.
10. Han KY, Gu X, Wang HR, Liu D, Lv FZ, Li JN: Overexpression of MAC30 is associated with poor clinical ou tcome in human non-small-cell lung cancer. Tumour Biol 2012;34:821-825.
11. Yan BY, Wang DW, Zhu ZL, Yang YH, Wang MW, Cui DS, Zhang H, Sun XF: Overexpression of MAC30 in the cytoplasm of o ral squamous cell carcinoma predicts nodal metastasis and poor differentiation. Chemotherapy 2010;56:424-428.
12. Hammill AK Uhr JW Scheuermann RH Annexin V staining due to loss of membrane asymmetry can be reversible and precede commitment to apoptotic death Exp Cell Res 1999 251 16-21. (Pubitemid 29406515)
13. Ma J, Sawai H, Ochi N, Matsuo Y, Xu D, Yasuda A, Takahashi H, Wakasugi T, Takeyama H: PTEN regulat es angiogenesis through PI3K/Akt/VEGF signaling pathway in human pancreatic cancer cells. Mol Cell Biochem 2009;331:161-171.
14. Zhao ZR, Zhang LJ, He XQ, Zhang ZY, Zhang F, Li F, Pei YB, Hu YM, Wang MW, Sun XF: Significance of mRNA and protein expression of MAC30 in progression of colorectal cancer. Chemotherapy 2011; 57:394-401.
15. Xiao M, Li H, Yang S, Huang Y, Jia S, Wang H, Wang J, Li Z: Expression of MAC30 protein is related to survival and clinicopathological variables in breast cancer. J Surg Oncol 20 12;107.
16. Han KY, Gu X, Wang HR, Liu D, Lv FZ, Li JN: Overexpression of MAC30 is associated with poor clinical outcome in human non-small-cell lung cancer. Tumour Biol 2013;34:821-825.
17. Vivanco I, Sawyers CL: The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat Rev Cancer 2002;2:489-501. (Pubitemid 37328931)
18. Xu XY, Zhang Z, Su WH, Zhang Y, Feng C, Zhao HM, Zong ZH , Cui C, Yu BZ: Involvement of the p110 alpha isoform of PI3K in early development of mouse embryos. Mol Reprod Dev 2009;76:389-398.
19. Guadagno TM, Newport JW: Cdk2 kinase is required for entry into mitosis as a positive regulator of Cdc2-cyclin B kinase activity. Cell 1996;84:73-82. (Pubitemid 26031462)
20. Yang LY, Tao YM, Ou DP, Wang W, Chang ZG, Wu F: Increased expression of Wiskott-Aldrich syndrome protein fam ily verprolin-homologous protein 2 correlated with poor prognosis of hepatocellular carcinoma. Clin Cancer Res 2006;12:5673-5679. (Pubitemid 44629594)
21. Yan C, Martinez-Quiles N, Eden S, Shibata T, Takeshima F, Shinkura R, Fujiwara Y, Bronson R, Snapper SB, Kirschner MW, Geha R, Rosen FS, Alt FW: WAVE2 deficiency reveals distinct roles in embryogenesis and Rac-mediated actin-based motility. Embo J 2003;22:3602-3612. (Pubitemid 36898337)
22. Kurisu S, Suetsugu S, Yamazaki D, Yamaguchi H, Takenawa T: Rac-WAVE2 signaling is involved in the invasive and metastatic phenotypes of murine melanoma cells. Oncogene 2005;24:1309-1319. (Pubitemid 40343111)
23. Yokotsuka M, Iwaya K, Saito T, Pandiella A, Tsuboi R, Kohno N, Matsubara O, Mukai K: Overexpression of HER2 signaling to WAVE2-Arp2/3 complex activates MMP-independent migration in breast cancer. Breast Cancer Res Tr eat 2011;126:311-318.
24. Yao Q, Cao Z, Tu C, Zhao Y, Liu H, Zhang S: MicroRNA-146a acts as a metastasis suppressor in gastric cancer by targeting WASF2. Cancer Lett 2013;335:219-224.
25. Xu XY, Xia P, Yu M, Nie XC, Yang X, Xing YN, Liu YP, Takano Y, Zheng HC: The roles of REIC gene and its encoding product in gastric carcinoma. Cell Cycle 2012;11:1414-1431.